BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8486432)

  • 1. Suppression of tumorigenicity in temperature-sensitive mutants of embryonal carcinoma cells by induction of cell differentiation at non-permissive temperature.
    Sumi T; Nishina Y; Kosaka M; Sakuda M; Nishimune Y
    Int J Cancer; 1993 May; 54(2):333-7. PubMed ID: 8486432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of mutants showing temperature-sensitive cell growth from embryonal carcinoma cells: control of stem cell differentiation by incubation temperatures.
    Nishimune Y; Nishina Y; Sumi T; Kosaka M; Takeda M; Matsumoto K; Matsushiro A; Sakuda M
    Biochem Biophys Res Commun; 1989 Nov; 165(1):65-72. PubMed ID: 2574037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-myc and p53 gene expression in the differentiation of temperature-sensitive mutants of teratocarcinoma F9 cells.
    Kosaka M; Iwai SA; Nishina Y; Sumi T; Nishimune Y
    Oncogene; 1992 Dec; 7(12):2455-60. PubMed ID: 1461650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the clonal growth and differentiation of feeder layer dependent mouse embryonal carcinoma cells by beta-mercaptoethanol.
    Oshima R
    Differentiation; 1978; 11(3):149-55. PubMed ID: 720785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant F9 embryonal carcinoma cell line which undergoes incomplete differentiation in retinoic acid.
    Moore EE; Moritz EA; Mitra NS
    Cancer Res; 1985 Sep; 45(9):4387-96. PubMed ID: 2992778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of hexamethylenebisacetamide on the differentiation of embryonal carcinoma cells].
    Jakob H; Dubois P; Eisen H; Jacob F
    C R Acad Hebd Seances Acad Sci D; 1978 Jan; 286(1):109-11. PubMed ID: 206377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
    Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
    Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of differentiation in teratocarcinoma stem cells by retinoic acid.
    Strickland S; Mahdavi V
    Cell; 1978 Oct; 15(2):393-403. PubMed ID: 214238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
    Rizzino A; Crowley C
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):457-61. PubMed ID: 6244561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
    Oredsson SM; Billgren M; Heby O
    Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between differentiation and tumorigenicity in temperature-sensitive mutants of teratocarcinoma F 9 cells].
    Sumi T
    Osaka Daigaku Shigaku Zasshi; 1987 Jun; 32(1):210-28. PubMed ID: 3504478
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyoma mutants that productively infect F9 embryonal carcinoma cells do not rescue wild-type polyoma in F9 cells.
    Fujimura FK; Linney E
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1479-83. PubMed ID: 6280185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo diffusion chamber culture reduces the tumorigenicity of PCC4-aza1 teratocarcinoma cells.
    Nomura T; Kameyama T
    Cancer Lett; 1987 Jan; 34(1):21-6. PubMed ID: 3802066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytoenzymology of the early differentiation of mouse embryonal carcinoma cells.
    Swartzendruber DE; Cox KZ; Wilder ME
    Differentiation; 1980 Feb; 16(1):23-30. PubMed ID: 7429065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent teratocarcinoma-derived cell lines stabilized by transformation with SV40 and SV40tsA mutant viruses.
    Maltzman W; Linzer DI; Brown F; Teresky AK; Rosenstraus M; Levine AJ
    Int Rev Cytol Suppl; 1979; (10):173-89. PubMed ID: 230162
    [No Abstract]   [Full Text] [Related]  

  • 17. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
    Lehtonen E; Laasonen A; Tienari J
    Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both D factor/LIF and IL-6 inhibit the differentiation of mouse teratocarcinoma F9 cells.
    Hirayoshi K; Tsuru A; Yamashita M; Tomida M; Yamamoto-Yamaguchi Y; Yasukawa K; Hozumi M; Goeddel DV; Nagata K
    FEBS Lett; 1991 May; 282(2):401-4. PubMed ID: 1903722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonal carcinoma cells adhere preferentially to fibronectin and laminin but their endodermal differentiation leads to a reduced adherence to laminin.
    Tienari J; Lehtonen E; Vartio T; Virtanen I
    Exp Cell Res; 1989 May; 182(1):26-32. PubMed ID: 2714404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
    Kohda T; Kondo K; Oishi M
    FEBS Lett; 1991 Sep; 290(1-2):107-10. PubMed ID: 1655528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.